The trajectory of click here companies tied to Viagra's past presents a complex investment picture . While the initial surge generated substantial returns , generic alternatives have significantly diminished revenue. Investing in related pharmaceutical firms now requires a careful assessment of patent rights , evolving healthcare shifts , and the p